INOPP Forum

VigiServe Foundation > INOPP Forum

INOPP ForumUnread Topics

You need to log in to create posts and topics.

Unread Topics

Re-inspections in the EUIn EU/EEA · 6 years ago

PRAC - Pharmacovigilance Risk Assessment CommitteeIn EU/EEA · 6 years ago

Regulatory Actions - Due to Inspection Findings!In EU/EEA · 6 years ago

What is a Market Research Programme?In Patient support programme · 6 years ago

What are Patient support programs?In Patient support programme · 6 years ago

RSI for Clinical TrialsIn Reference Safety Information · 6 years ago

Types of Reference Safety Information (RSI)In Reference Safety Information · 6 years ago

Definition and the need for PAESIn Post Authorization Efficacy Studies (PAES) · 6 years ago

Local Literature MonitoringIn Literature Management · 6 years ago

Implementation of Safety Changes in the ArtworksIn Safety Labeling · 6 years ago

Causality for Veterinary Medicinal ProductsIn Causality Assessment · 6 years ago

L2A, L2B and MLM - export FunctionIn Eudravigilance L2A and L2B Case Reports · 6 years ago

EMA - Medical literature monitoringIn Literature Management · 6 years ago

Monitoring of Medical LiteratureIn Literature Management · 6 years ago

Learning AddictoVigilanceIn AddictoVigilance · 6 years ago

Signal Management in the European UnionIn Signal Management · 6 years ago

Pharmacovigilance requirements in UruguayIn Uruguay · 6 years ago

Type 1B variations in the European Union/UKIn Safety Variations · 6 years ago

Type II Variation in the European Union and the UKIn Safety Variations · 6 years ago

Definition of Safety VariationIn Safety Variations · 6 years ago

What are Urgent Safety Restrictions?In Urgent Safety Restrictions · 6 years ago

Safety Signal - An IntroductionIn Signal Management · 6 years ago

Population RegistriesIn Patient Registries · 6 years ago

Conceptual differences between Registries and StudiesIn Patient Registries · 6 years ago

Additional Risk Minimisation MeasuresIn Risk Management · 6 years ago

How does MedSafe monitor vaccine safety?In New Zealand · 6 years ago

Defining a New IndicationIn Defining a New Indication · 6 years ago

Paediatric investigation plansIn Paediatric investigation plans · 6 years ago

Pharmacovigilance Requirements in MoldovaIn Moldova · 6 years ago

Escalations - MHRA GPVP Non-ComplianceIn United Kingdom · 6 years ago

MHRA GPVP InspectionsIn United Kingdom · 6 years ago

Routine risk minimisation activitiesIn Risk Management · 6 years ago

Important Identified RisksIn Risk Management · 6 years ago

Missing InformationIn Risk Management · 6 years ago

Important Potential RisksIn Risk Management · 6 years ago

MHRA - Good pharmacovigilance practice (GPvP)In United Kingdom · 6 years ago

Regional Risk Management RequirementsIn Risk Management · 6 years ago

Vaccine Pharmacovigilance in IndiaIn Pharmacovigilance Requirements in India · 6 years ago

DiLi - Drug Induced Liver InjuryIn DiLi - Drug Induced Liver Injury · 6 years ago

Medsafe Safety CommunicationsIn New Zealand · 6 years ago

SMARS DATABASE - Suspected Medicine Adverse Reaction SearchIn New Zealand · 6 years ago

What are PASS Studies?In Post Authorization Safety Studies (PASS) · 6 years ago

Pharmacovigilance Requirements in KuwaitIn Kuwait · 6 years ago

Lack of efficacy - VeterinaryIn Coding Veterinary Adverse Events · 6 years ago

Coding Veterinary Adverse EventsIn Coding Veterinary Adverse Events · 6 years ago

Human Adverse ReactionIn Coding Veterinary Adverse Events · 6 years ago

Cosmetovigilance requirements in ChinaIn China Cosmetovigilance · 6 years ago

Medical Device Vigilance Requirements in ChinaIn China · 6 years ago

Vaccine Safety Monitoring in ChinaIn China · 6 years ago

Pharmacovigilance requirements in ChinaIn China · 6 years ago